The Increased Demand for Immune Globulin Products and Its Effects on Patient Access

In this first episode, we will be talking about the increased demand for immune globulin (IG) products and its effect on patient access. This is our first podcast episode of IG Living Advocate and a transition from our Readers Teleconferences. With this podcast, we have an opportunity for our readers to hear from healthcare experts on topics important to them. In this first episode, we will be talking about the increased demand for immune globulin (IG) products and its effect on patient access. Today, we have with us guest expert Patrick M. Schmidt, chief executive officer of FFF Enterprises, also known as triple F, and Nufactor, a Specialty Infusion Company. Patrick has been with FFF since its inception in 1988. In 1995, FFF launched Nufactor to address the high costs and access issues related to IG therapy. Patrick is recognized as a leader in the healthcare community, having introduced several industry firsts that have paved the way to create solutions to challenges faced by both healthcare providers and their patients.Support the show